Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids

NCT05123040 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Sponsor terminated financial support

Conditions

Acute-graft-versus-host Disease

Interventions

DRUG: Ruxolitinib 10 MG Oral Tablet
DRUG: hCG
DRUG: Corticosteroids

Sponsor

Masonic Cancer Center, University of Minnesota